2-[[4-[[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]amino]-3-pyridinyl]oxy]ethanol;2-(3-chlorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;2-(2,5-difluorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;2-(2-fluorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;N-pyridin-4-yl-2-[3-(trifluoromethyl)phenyl]-1,8-naphthyridin-4-amine
C98H67Cl2F7N20O2 — CID 159917775
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[4-[[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]amino]-3-pyridinyl]oxy]ethanol;2-(3-chlorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;2-(2,5-difluorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;2-(2-fluorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;N-pyridin-4-yl-2-[3-(trifluoromethyl)phenyl]-1,8-naphthyridin-4-amine
2-[[4-[[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]amino]-3-pyridinyl]oxy]ethanol;2-(3-chlorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;2-(2,5-difluorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;2-(2-fluorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;N-pyridin-4-yl-2-[3-(trifluoromethyl)phenyl]-1,8-naphthyridin-4-amine (PubChem CID 159917775) has the molecular formula C98H67Cl2F7N20O2 and a molecular weight of 1760.64 g/mol. Its IUPAC name is 2-[[4-[[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]amino]-3-pyridinyl]oxy]ethanol;2-(3-chlorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;2-(2,5-difluorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;2-(2-fluorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;N-pyridin-4-yl-2-[3-(trifluoromethyl)phenyl]-1,8-naphthyridin-4-amine.
Molecular Properties
| Compound Name | 2-[[4-[[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]amino]-3-pyridinyl]oxy]ethanol;2-(3-chlorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;2-(2,5-difluorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;2-(2-fluorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;N-pyridin-4-yl-2-[3-(trifluoromethyl)phenyl]-1,8-naphthyridin-4-amine |
|---|---|
| PubChem CID | 159917775 |
| Molecular Formula | C98H67Cl2F7N20O2 |
| Molecular Weight | 1760.64 g/mol |
| Exact Mass | 1758.50 |
| IUPAC Name | 2-[[4-[[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]amino]-3-pyridinyl]oxy]ethanol;2-(3-chlorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;2-(2,5-difluorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;2-(2-fluorophenyl)-N-pyridin-4-yl-1,8-naphthyridin-4-amine;N-pyridin-4-yl-2-[3-(trifluoromethyl)phenyl]-1,8-naphthyridin-4-amine |
| SMILES | Clc1cccc(-c2cc(Nc3ccncc3)c3cccnc3n2)c1.FC(F)(F)c1cccc(-c2cc(Nc3ccncc3)c3cccnc3n2)c1.Fc1ccc(F)c(-c2cc(Nc3ccncc3)c3cccnc3n2)c1.Fc1ccccc1-c1cc(Nc2ccncc2)c2cccnc2n1.OCCOc1cnccc1Nc1cc(-c2cc(Cl)ccc2F)nc2ncccc12 |
| InChI | InChI=1S/C21H16ClFN4O2.C20H13F3N4.C19H13ClN4.C19H12F2N4.C19H13FN4/c22-13-3-4-16(23)15(10-13)19-11-18(14-2-1-6-25-21(14)27-19)26-17-5-7-24-12-20(17)29-9-8-28;21-20(22,23)14-4-1-3-13(11-14)17-12-18(26-15-6-9-24-10-7-15)16-5-2-8-25-19(16)27-17;20-14-4-1-3-13(11-14)17-12-18(23-15-6-9-21-10-7-15)16-5-2-8-22-19(16)24-17;20-12-3-4-16(21)15(10-12)18-11-17(24-13-5-8-22-9-6-13)14-2-1-7-23-19(14)25-18;20-16-6-2-1-4-14(16)17-12-18(23-13-7-10-21-11-8-13)15-5-3-9-22-19(15)24-17/h1-7,10-12,28H,8-9H2,(H,24,25,26,27);1-12H,(H,24,25,26,27);1-12H,(H,21,22,23,24);1-11H,(H,22,23,24,25);1-12H,(H,21,22,23,24) |
| InChIKey | NXZVDMVMJGRTGE-UHFFFAOYSA-N |
| XLogP | 24.43 |
| TPSA | 282.96 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 129 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1760.64 |
| LogP ≤ 5 | 24.43 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 22 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159917775 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.